HPE Private Cloud Enterprise will enhance scalability and operational performance for Lupin. BENGALURU, India, April 23, 2025--(BUSINESS WIRE)--Hewlett Packard Enterprise (NYSE: HPE) today ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for tolvaptan ...

Mumbai: Indian generics drug maker, Lupin wholly owned diagnostic arm Lupin Diagnostics Limited (LDL) has obtained NABL (National Accreditation Board for Testing and Calibration Laboratories ...

Shares of Lupin Ltd. edged 2.5 percent higher on Wednesday after the company announced the launch of Tolvaptan tablets in the US market, marking a key milestone in its US generics portfolio.

Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of Tolvaptan tablets indicated for a certain type of kidney disease.

Generic drugmaker Lupin has received U.S. Food and Drug Administration approval for Tolvaptan tablets of different strengths. It is the exclusive first-to-file for this product and consequently ...

Lupin gets US FDA approval for Tolvaptan tablets. Tolvaptan tablets to be produced at Nagpur facility. Market exclusivity granted for 180 days in the US. Lupin Limited on Thursday said it received ...

The gradual upward movement suggests the beginning of a new bullish leg from current levels. Lupin has given a breakout from its symmetrical triangle chart pattern with a strong bullish candlestick.

Share of Lupin Ltd. are trading with gains of about 3% on Wednesday, April 23, following news of a key product launch. Lupin is set to launch gTolvaptan (the generic version of Jynarque) in the US ...